Advances in Multiple Sclerosis and Experimental Demyelinating Diseases

By Moses Rodriguez

Book Overview

Benign Multiple Sclerosis: A Distinct Clinical Entity with Therapeutic Implications.- Pathological Heterogeneity of Idiopathic Central Nervous System Inflammatory Demyelinating Disorders.- Multiple Sclerosis Genetics.- Imaging of Remyelination and Neuronal Health.- Immunological Aspects of Axon Injury in Multiple Sclerosis.- The Multiple Sclerosis Degradome: Enzymatic Cascades in Development and Progression of Central Nervous System Inflammatory Disease.- Genetic Analysis of CNS Remyelination.- Remyelination in Experimental Models of Toxin-Induced Demyelination.- Remyelination-Promoting Human IgMs: Developing a Therapeutic Reagent for Demyelinating Disease.- Neuroimaging of Demyelination and Remyelination Models.- Hormonal Influences in Multiple Sclerosis.- Statins and Demyelination.- Role of Uric Acid in Multiple Sclerosis.- Neuromyelitis Optica: Clinical Syndrome and the NMO-IgG Autoantibody Marker.

• Format: Paperback
• Language: English
• ISBN: 3642437834
• ISBN13: 9783642437830
• Release Date: September 2014
• Publisher: Springer
• Length: 362 Pages
• Weight: 1.17 lbs.
• Dimensions: 0.8" x 6.1" x 9.2"